Clinical Trials in Maryland

Showing 6621-6640 of 17,687 trials

Hostile Bias Modification Training (HBMT) Study

NCT04997356

The primary objective of the present protocol is to evaluate the effectiveness of real HBMT versus placebo on reducing HAB and aggression. The secondary objectives of the present protocol are: 1. Investigate the role of individual difference variables on HAB, interpersonal aggression, and effects of HBMT. 2. Collect vocal recording data to inform the development of algorithms to predict emotional stress from changes in speech.

AngerStressAggression

Walter Reed Army Institute of Research (WRAIR)165 participantsStarted Aug 2021

Silver Spring, Maryland, United States

COMPLETEDPhase 217 miles

Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy

NCT03373383

The purpose of the study is to characterize the dose-response relationship with respect to efficacy of Padsevonil administered concomitantly with up to 3 anti-epileptic drugs (AEDs) for treatment of observable focal-onset seizures in subjects with drug-resistant epilepsy.

Drug-resistant EpilepsyFocal-Onset Seizures

UCB Biopharma S.P.R.L.411 participantsStarted Feb 2018

Chandler, Arizona, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +145 more locations

Hostile Bias Modification Training (HBMT) Study

Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy

Find Trials by Condition in Maryland

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)

Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study

A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease

A Study of Enzyme Replacement Therapy (VPRIV) in People With Type 1 Gaucher Disease Who Were Previously Treated With Substrate Reduction Therapy

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Study of the CD40 Agonistic Monoclonal Antibody APX005M

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee

Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

Medibio DDA Confirmatory Performance Study

A Study to Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia